Catalyst
Description
  • Value proposition

    Our Vision : We have High Standards - We Build Companies - We have Impact

    Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).

    Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech

  • Original language

    Our Vision : We have High Standards - We Build Companies - We have Impact

    Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).

  • Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe

    Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe

  • https://www.kurmapartners.com/en
Entity interactions
Entity TypeTweets Articles
Switzerland Global Enterprise Switzerland Global Enterprise
International Trade and Development
Other

25 Nov 2020


Dynacure Dynacure
Biotechnology Research, biotech, deeptech
Capitalistic
Not partnership
Not event

2 Apr 2020

2 Mar 2023



BaseLaunch BaseLaunch
Biotechnology Research
Other

2 Feb 2021


Arkhn Arkhn
Hospitals and Health Care, healthtech, it services
Capitalistic
Partnership
Not event

19 May 2021

15 Oct 2024



MATWIN MATWIN
Research Services, deeptech
Other

28 Apr 2021

28 Nov 2024



Institut Imagine Institut Imagine
Research Services, biotech, deeptech
Other

21 Nov 2017


Omnidoc Omnidoc
IT Services and IT Consulting, healthtech
Capitalistic
Partnership
Not event

10 Jun 2021


LSX LSX
Other

1 Sep 2020


WanSquare WanSquare
Writing and Editing
Other

27 Sep 2021


BioPharmAnalyses BioPharmAnalyses
Research Services, biotech, deeptech
Capitalistic
Not partnership
Not event

24 Sep 2021


Radars
Loading...